Agenus maintains a world footprint via collaborations and partnerships with primary pharmaceutical and biotechnology organizations in North The united states, Europe and Asia. Its agreements contain research and growth collaborations, license arrangements and co-advancement applications targeted at accelerating the translation of novel immunotherap